Your browser doesn't support javascript.
loading
Counting Costs under Severe Financial Constraints: A Cost-of-Illness Analysis of Spondyloarthropathies in a Tertiary Hospital in Greece.
Tsifetaki, Niki; Migkos, Michail P; Papagoras, Charalampos; Voulgari, Paraskevi V; Athanasakis, Kostas; Drosos, Alexandros A.
Afiliación
  • Tsifetaki N; From the Department of Rheumatology, General Hospital "G. Hatzikosta"; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina; Laboratory of Molecular Hematology, Medical School, Democritus University of Thrace, Alexandroupolis; Department of Health Ec
  • Migkos MP; From the Department of Rheumatology, General Hospital "G. Hatzikosta"; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina; Laboratory of Molecular Hematology, Medical School, Democritus University of Thrace, Alexandroupolis; Department of Health Ec
  • Papagoras C; From the Department of Rheumatology, General Hospital "G. Hatzikosta"; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina; Laboratory of Molecular Hematology, Medical School, Democritus University of Thrace, Alexandroupolis; Department of Health Ec
  • Voulgari PV; From the Department of Rheumatology, General Hospital "G. Hatzikosta"; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina; Laboratory of Molecular Hematology, Medical School, Democritus University of Thrace, Alexandroupolis; Department of Health Ec
  • Athanasakis K; From the Department of Rheumatology, General Hospital "G. Hatzikosta"; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina; Laboratory of Molecular Hematology, Medical School, Democritus University of Thrace, Alexandroupolis; Department of Health Ec
  • Drosos AA; From the Department of Rheumatology, General Hospital "G. Hatzikosta"; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina; Laboratory of Molecular Hematology, Medical School, Democritus University of Thrace, Alexandroupolis; Department of Health Ec
J Rheumatol ; 42(6): 963-7, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25834213
OBJECTIVE: To investigate the total annual direct cost of patients with spondyloarthritis (SpA) in Greece. METHODS: Retrospective study with 156 patients diagnosed and followed up in the rheumatology clinic of the University Hospital of Ioannina. Sixty-four had ankylosing spondylitis (AS) and 92 had psoriatic arthritis (PsA). Health resource use for each patient was elicited through a retrospective chart review that documented the use of monitoring visits, medications, laboratory/diagnostic tests, and inpatient stays for the previous year from the date that the review took place. Costs were calculated from a third-party payer perspective and are reported in 2014 euros. RESULTS: The mean ± SD annual direct cost for the patients with SpA reached €8680 ± 6627. For the patients with PsA and AS, the cost was estimated to be €8097 ± 6802 and €9531 ± 6322, respectively. The major cost was medication, which represented 88.9%, 88.2%, and 89.3% of the mean total direct cost for SpA, AS, and PsA, respectively. The annual amount of the scheduled tests for all patients corresponded to 7.5%, and for those performed on an emergency basis, 1.1%. Further, the cost for scheduled and emergency hospitalization, as well as the cost of scheduled visits to an outpatient clinic, corresponded to 2.5% of the mean total annual direct cost for the patients with SpA. CONCLUSION: SpA carries substantial financial cost, especially in the era of new treatment options. Adequate access and treatment for patients with SpA remains a necessity, even in times of fiscal constraint. Thus, the recommendations of the international scientific organizations should be considered when administering high-cost drugs such as biological treatments.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Psoriásica / Costo de Enfermedad / Antirreumáticos / Espondiloartropatías / Anticuerpos Monoclonales Humanizados / Reembolso de Seguro de Salud Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Health_economic_evaluation / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Rheumatol Año: 2015 Tipo del documento: Article Pais de publicación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Psoriásica / Costo de Enfermedad / Antirreumáticos / Espondiloartropatías / Anticuerpos Monoclonales Humanizados / Reembolso de Seguro de Salud Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Health_economic_evaluation / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Rheumatol Año: 2015 Tipo del documento: Article Pais de publicación: Canadá